LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

LLY

1,076.31

+0.13%↑

JNJ

207.79

+1.08%↑

ABBV

230.14

+0.15%↑

UNH

327.75

+0.78%↑

AZN

92.5

+0.34%↑

Inicio・Lista de Acciones・Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals Inc

Cerrado

SectorSanidad

9.61 0.42

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

9.47

Máximo

9.81

Métricas clave
By Trading Economics
Ingresos	11M -20M
Ventas	5.9M 40M
BPA	-0.19
Margen de beneficios	-49.569
Empleados	184
EBITDA	16M -19M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+148.17% upside

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	234M 983M
Apertura anterior	9.19
Cierre anterior	9.61

Noticias sobre sentimiento de mercado

By Acuity

92%

6 / 374 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Very Strong Bearish Evidence

6.26 / 7.47 Soporte y Resistencia

Day One Biopharmaceuticals Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 dic 2025, 21:41 UTC

Adquisiciones, fusiones, absorciones

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

24 dic 2025, 14:57 UTC

Adquisiciones, fusiones, absorciones

Accenture to Acquire Cabel Industry from Fibonacci Group

24 dic 2025, 12:48 UTC

Principales Movimientos del Mercado

Adquisiciones, fusiones, absorciones

Repare Therapeutics Shares Rise on $30 Million Asset Deal With Gilead

24 dic 2025, 12:21 UTC

Principales Movimientos del Mercado

Nike Shares Tick Up After Apple CEO Tim Cook Buys $2.9 Million of Its Stock

24 dic 2025, 22:22 UTC

Adquisiciones, fusiones, absorciones

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 dic 2025, 21:26 UTC

Adquisiciones, fusiones, absorciones

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24 dic 2025, 19:35 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

24 dic 2025, 19:35 UTC

Charlas de Mercado

Treasury Yields Decline Ahead of Christmas -- Market Talk

24 dic 2025, 19:09 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Global Equities Roundup: Market Talk

24 dic 2025, 19:09 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24 dic 2025, 19:06 UTC

Charlas de Mercado

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

24 dic 2025, 19:03 UTC

Charlas de Mercado

U.S. Natural Gas Futures Give Back Some Gains -- Market Talk

24 dic 2025, 17:20 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Tech, Media & Telecom Roundup: Market Talk

24 dic 2025, 17:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

24 dic 2025, 17:08 UTC

Adquisiciones, fusiones, absorciones

This Biotech Stock Soars 39%. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 dic 2025, 16:53 UTC

Adquisiciones, fusiones, absorciones

Nike Climb Boosts Dow, S&P 500 -- WSJ

24 dic 2025, 16:31 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

ServiceNow Gets Top-Tier Asset and Talent With Armis Buy -- Market Talk

24 dic 2025, 16:28 UTC

Adquisiciones, fusiones, absorciones

Lam Research Is at All-Time Highs. Its CEO Just Sold $27 Million Worth of Stock. -- Barrons.com

24 dic 2025, 16:17 UTC

Charlas de Mercado

Dollar Stable as U.S. Layoffs Remain at Bay -- Market Talk

24 dic 2025, 15:33 UTC

Adquisiciones, fusiones, absorciones

Nike Shares Get a Lift After Apple's Tim Cook Doubles His Personal Stake -- WSJ

24 dic 2025, 15:30 UTC

Adquisiciones, fusiones, absorciones

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dic 2025, 15:19 UTC

Adquisiciones, fusiones, absorciones

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dic 2025, 14:49 UTC

Adquisiciones, fusiones, absorciones

Mexico's Ollamani Sells Stake in Azteca Stadium

24 dic 2025, 14:19 UTC

Charlas de Mercado

U.S. Natural Gas Futures Move Lower After Big Jump -- Market Talk

24 dic 2025, 14:08 UTC

Adquisiciones, fusiones, absorciones

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

24 dic 2025, 14:06 UTC

Charlas de Mercado

Oil Futures Edge Up on Geopolitical Risk Premium -- Market Talk

24 dic 2025, 13:24 UTC

Charlas de Mercado

Canada's Economy Needs More Help Amid Dismal GDP Report -- Market Talk

24 dic 2025, 12:59 UTC

Adquisiciones, fusiones, absorciones

This Biotech Stock Is Soaring. Sanofi Is Buying It for $2.2 Billion. -- Barrons.com

24 dic 2025, 12:51 UTC

Adquisiciones, fusiones, absorciones

Disney Could Be the Real Winner from the Warner Takeover Battle. Here's Why. -- Barrons.com

24 dic 2025, 12:38 UTC

Adquisiciones, fusiones, absorciones

Apple CEO Tim Cook Buys $3 Million of Nike Shares. The Stock Is Rising. -- Barrons.com

Comparación entre iguales

Cambio de precio

Day One Biopharmaceuticals Inc previsión

Precio Objetivo

By TipRanks

148.17% repunte

Estimación a 12 Meses

Media 23.75 USD 148.17%

Máximo 34 USD

Mínimo 16 USD

De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Day One Biopharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

9 ratings

Comprar

Mantener

Vender

De acuerdo con 9 analistas que ofrecen calificaciones bursátiles a para Day One Biopharmaceuticals Inc Dist en los últimos 3 meses.

Puntuación técnica

By Trading Central

6.26 / 7.47Soporte y Resistencia

Recent bearish events outweigh bullish events.

All events are bullish.

All events are bearish.

Sentimiento

By Acuity

6 / 374 Clasificación en Sanidad

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Day One Biopharmaceuticals Inc

Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genomically defined cancers. Its lead product candidate is tovorafenib, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric patients with relapsed/ refractory low-grade glioma. The company is also developing Pimasertib, an oral small molecule inhibitor of mitogen-activated protein kinase kinases 1 and 2. Day One Biopharmaceuticals, Inc. was incorporated in 2018 and is headquartered in Brisbane, California.